MedPath

ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment

Not Applicable
Completed
Conditions
End Stage Renal Disease
Interventions
Procedure: Duplex ultrasonography
Registration Number
NCT01597115
Lead Sponsor
Seoul National University Hospital
Brief Summary

The aim of this study is to evaluate whether Aggressive duplex surveillance after vascular access surgery with native vein for hemodialysis can increase the maturation rate of arteriovenous fistula. This study will be conducted as a single center, prospective, 1:1 randomized study. Enrolled patients will be randomized as a control group (Physical exam at 2 and 4 weeks after surgery) and duplex group (duplex study and physical exam at 2 and 4 weeks after surgery). Maturation of arteriovenous fistula will be evaluated at 8 weeks after surgery by duplex in all patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • end stage renal disease
  • newly formed hemodialysis access with native vein
  • 20~70 years
Read More
Exclusion Criteria
  • hemodialysis access surgery with ePTFE graft
  • hemodialysis access surgery with basilic vein transposition
  • hemodialysis access surgery with brachial vein transposition
  • cephalic vein < 2.5mm in diameter
  • radial artery diameter <2.0mm in radiocephalic arteriovenous fistula
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DuplexDuplex ultrasonographyPatients in this group will be examed by duplex ultrasonography at 2 and 4 weeks after surgery
Primary Outcome Measures
NameTimeMethod
hemodialysis access maturation rate8 weeks after surgery
Secondary Outcome Measures
NameTimeMethod
factors predicting maturation failure8 weeks after surgery

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath